Source Paper
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
Belén G. Ramírez, Cristina Blázquez, Teresa Gómez del Pulgar, Manuel Guzmán, María L. de Ceballos
Journal of Neuroscience • 2005
Intracerebroventricular WIN55,212-2 Administration in Rats
Objective: To assess whether intracerebroventricular administration of synthetic cannabinoid WIN55,212-2 prevents β-amyloid-induced microglial activation, cognitive impairment, and loss of neuronal markers in rats
Gather these items before starting the experiment. Check off items as you prepare.
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Protocol Steps
Intracerebroventricular Administration
Administer WIN55,212-2 intracerebroventricularly to rats
Note: This is the primary intervention in the in vivo experiment
View evidence from paper
“Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent β-amyloid-induced microglial activation, cognitive impairment, and loss of neuronal markers”
β-Amyloid Treatment
Treat rats with β-amyloid peptide following WIN55,212-2 administration
Note: Timing and dosage of β-amyloid administration not specified in provided text
View evidence from paper
“Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent βA-induced microglial activation, cognitive impairment, and loss of neuronal markers”
Cognitive Assessment
Assess cognitive impairment in treated rats
Note: Specific cognitive tests not detailed in provided text
View evidence from paper
“prevent βA-induced microglial activation, cognitive impairment, and loss of neuronal markers”
Microglial Activation Analysis
Evaluate microglial activation status in brain tissue
Note: Methods for assessing microglial activation not specified in provided text
View evidence from paper
“Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent βA-induced microglial activation”
Neuronal Marker Assessment
Measure loss of neuronal markers in brain tissue
Note: Specific neuronal markers and measurement methods not detailed in provided text
View evidence from paper
“prevent βA-induced microglial activation, cognitive impairment, and loss of neuronal markers”